A popular diabetes and weight-loss drug reduced people’s craving for drinking alcohol.
The results, from the first clinical trial of its kind, suggest that semaglutide may hold promise as a treatment for problematic alcohol use. Semaglutide is sold as Ozempic and Wegovy.
Some people have reported that this family of drugs, called GLP-1 agonists, curbs not just the desire to eat, but also to drink alcohol and smoke cigarettes. Data from mice, rats and nonhuman primates back that up. But clear evidence from people was lacking.
.email-conversion { border: 1px solid #ffcccb; color: white; margin-top: 50px; background-image: url(“/wp-content/themes/sciencenews/client/src/images/[email protected]”); padding: 20px; clear: both; }